Walgreens Stock Has 'Run Too Far' on Deal Optimism, Analysts Say

1. Walgreens shares fell 5% amid sale speculation and analyst downgrades. 2. Deutsche Bank cut WBA's price target to below $9, citing overspeculation. 3. Retail pharmacy fundamentals are eroded, posing challenges for U.S. operations. 4. WBA plans to close 1,200 stores as part of a turnaround strategy. 5. Recent net earnings reflect losses of $256 million, adjusted profit at $440 million.